Parallel Advisors’s Anika Therapeutics ANIK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-39
| Closed | -$963 | – | 3499 |
|
|
2024
Q3 | $963 | Hold |
39
| – | – | ﹤0.01% | 3031 |
|
|
2024
Q2 | $988 | Hold |
39
| – | – | ﹤0.01% | 2945 |
|
|
2024
Q1 | $991 | Buy |
+39
| New | +$991 | ﹤0.01% | 2932 |
|
|
2023
Q4 | – | Sell |
-14
| Closed | -$261 | – | 3303 |
|
|
2023
Q3 | $261 | Sell |
14
-99
| -88% | -$1.85K | ﹤0.01% | 3205 |
|
|
2023
Q2 | $2.94K | Buy |
113
+29
| +35% | +$753 | ﹤0.01% | 2624 |
|
|
2023
Q1 | $2.41K | Hold |
84
| – | – | ﹤0.01% | 2698 |
|
|
2022
Q4 | $2.49K | Hold |
84
| – | – | ﹤0.01% | 2603 |
|
|
2022
Q3 | $2K | Buy |
84
+78
| +1,300% | +$1.86K | ﹤0.01% | 2557 |
|
|
2022
Q2 | $0 | Buy |
+6
| New | – | ﹤0.01% | 2949 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2269 |
|
|
2018
Q4 | – | Sell |
-211
| Closed | -$9K | – | 2106 |
|
|
2018
Q3 | $9K | Hold |
211
| – | – | ﹤0.01% | 1460 |
|
|
2018
Q2 | $6K | Hold |
211
| – | – | ﹤0.01% | 1509 |
|
|
2018
Q1 | $10K | Hold |
211
| – | – | ﹤0.01% | 1244 |
|
|
2017
Q4 | $11K | Hold |
211
| – | – | ﹤0.01% | 1257 |
|
|
2017
Q3 | $11K | Hold |
211
| – | – | ﹤0.01% | 1236 |
|
|
2017
Q2 | $11K | Buy |
+211
| New | +$11K | ﹤0.01% | 1262 |
|